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A retrospective study of central nervous system (CNS) in 284 autopsy AIDS cases in Brazil (1989–2008) divided into 3 groups:
A (without antiretroviral treatment: 163 cases); B (other antiretroviral therapies: 76 cases); C (HAART for 3 months or more: 45
cases). In 165 (58.1%) cases, relevant lesions were found, predominantly infections (54.2%); the most frequent was toxoplasmosis
(29.9%) followed by cryptococcosis (15.8%), purulent bacterial infections (3.9%), and HIV encephalitis (2.8%); non-Hodgkin
lymphomas occurred in 1.4% and vascular lesions in 1.1%. There was no diﬀerence when compared the frequency of lesion
among the groups; however, toxoplasmosis was less common while HIV encephalitis was more frequent in group C related to A.
CNS lesions remain a frequent cause of death in AIDS; however, the mean survival time was four times greater in group C than
in A. In 91 (55.1%) of 165 cases with relevant brain lesions (or 32% of the total 284 cases), there was discordance between pre-
and postmortem diagnosis; disagreement type 1 (important disease that if diagnosed in life could change the patient prognosis)
occurred in 49 (53.8%) of 91 discordant cases (17.6% of the total 284) indicating the autopsy importance, even with HAART and
advanced diagnostics technologies.
1.Introduction
The CNS is the second most-aﬀected organ in AIDS, second
only to the lung [1–4]. The immunity deﬁciency triggered by
HIV favors the development of infections by opportunistic
agents, being Toxoplasma gondii, Cryptococcus neoformans,
and cytomegalovirus the most common in CNS [5–8];
regarding cancer predominates primary non-Hodgkin lym-
phomas [2, 9]. HIV-speciﬁc lesions appear, in general, later
in the evolution of the disease, with giant multinucleated
cells often found, considered to be “pathognomonic” of HIV
infection in CNS [10, 11]. Necropsy is an important method
to understand not only the natural course of a disease, but
it also enables, through acquired knowledge, a better clini-
cal approach in providing patients with early diagnosis, bet-
ter management of patients with AIDS, and the election
of a prevention option [3, 8]. Necropsy is also a valuable
tool for recognizing clinically undiagnosed infections and2 AIDS Research and Treatment
malignant neoplasms [12–14]. However, systematic studies
of autopsy series from HIV-positive patients evaluating the
neuropathological ﬁndings are infrequent and most have
evaluated the pre-HAART period [4, 5, 7, 9, 15–18]a n d
even scarcer are post-HAART studies [2, 3, 19–23], perhaps
because there was an important reduction in the number
of autopsies from HIV-positive patients [3, 19, 21, 22].
However, they remain important even after HAART, as
changes occurred after that therapy, such as a decrease in
opportunistic infectionsandtheincreaseofHIVencephalitis
[24], at least in developed countries, although in the rest of
the world, in over 90% of AIDS cases, patients do not survive
long enough to present HIV neurological complications
[25]. However, these autopsy studies are even rarer in
developing countries, which makes it diﬃcult to establish
the true prevalence of the neuropathological lesions [26].
The importance of these studies can be felt when analyzing
the frequencies of some diseases, for example, tuberculosis
meningitis, which was seen in 12% of HIV autopsies in India
[16], similar frequency to that found in Africa (11%), while
in the USA occurred in only 1.4% of cases [27]. Though, we
foundnocomparativestudyofCNSﬁndingsbeforeandafter
HAART on autopsy series in developing countries (through
Medline search).
Among the autopsy series that analyzes changes in the
CNS pre- and post-HAART, Masliah et al. [3]c o m p a r e d
the frequency of lesions per year for 15 years (1982 to
1998), but they did not separate those cases by groups and
do not mention how many did or did not use HAART. It
was observed a decrease in opportunistic infections and an
increase of HIV encephalitis in the last years of the study.
Jellingeretal.[2]andM orgelloetal.[20]separatedintothree
periods,accordingtothetherapeuticregimenatthetime,but
did not evaluate data regarding the use of HAART. Neuen-
burg et al. [21]a n dV a g oe ta l .[ 22] divided the years re-
searched into four periods, the last one corresponding to
the HAART period; in the Neuenburg et al. [21]s t u d yo n l y
24 (57%) of 42 patients from this last period were using
such medication and Vago et al. [22] found 96 (90.6%) of
106 patients using HAART, but do not refer for how long.
Gray et al. [19] evaluated 23 cases of autopsies who received
HAART for at least 3 months before death, and Walsh et al.
[23] evaluated 11 cases in the post-HAART era, however, 2
neverusedsuchmedicationandonly2(12.5%)usedHAART
more than 3 months without interrupting the use of more
than 2 months before death. This last study, although in a
small series, shows that relying only on the time of autopsy,
as occurred in most studies, may not reﬂect the reality on the
use of medication. These data are important because there is
an initial rapid increase in CD4 counts in the ﬁrst 3 months
of therapy, although still generally increasing more slowly in
subsequent years [28], observing a signiﬁcant improvement
of immunity in the ﬁrst 3–6 months [29], and do not use
HAART for more than 2 months characterizes abandonment
with loss of the medication beneﬁt [30].
Wilkes et al. [14] highlight the value of autopsy in AIDS
to the correlation between pre- and postmortem. From 101
autopsies evaluated, 74% cases of AIDS-related illnesses were
not suspected clinically, such as cytomegalovirus (49%),
fungal systemic (20%), Kaposi’s sarcoma (14%), mycobac-
teriosis (11%) and CNS lymphoma (4%). Comparison of
pre- and postmortem ﬁndings in AIDS was also performed
by Antinori et al. [31] in 1630 autopsies, between 1984
and 2002, divided into four periods according to the use of
antiretroviral therapy; however, only invasive fungal infec-
tions were evaluated. They found invasive fungal infections
in 297 cases, which 54.2% were not suspected clinically, with
no variation in percentage over the periods. In 38 (36.9%)
of 103 cases in which mycosis was the main disease, the
diagnosis was not suspected premortem, and in 17 (45%) of
these 38 cases, the error would be Goldman’s type I. This
study conﬁrms the value of autopsy in AIDS patients, even
in the HAART era.
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lesions in AIDS autopsies over 20 years, according to antire-
troviral therapy, to assess whether there were changes in
the pattern of lesions and in survival time among the study
groups and if relevant lesions to death were suspected clini-
cally.
2.MaterialandMethods
This study was approved by the Research Ethics Committee
from the Federal University of Triˆ angulo Mineiro (number
831). It is a retrospective study of consecutive autopsies from
HIV-positive patients (minimum time of hospitalization 24
hours) performed in a teaching hospital in Uberaba, MG,
Brazil, from January 1989 to December 2008. From 1989,
we adopted a systematic collection of blood from all autopsy
cases, to conduct HIV testing. Clinical reports obtained from
medical records and autopsy requests were written in a form,
registering all clinical hypotheses made to the CNS, use or
not of antiretroviral therapy (type and duration of use), sur-
vivaltimeafterHIVinfectiondiagnosis,causeofdeathstated
intheautopsyreportandmorphologicaldatafromallorgans
obtained in the autopsy report, and adding CNS microscopic
review, in all cases, by the author of this study. Data con-
cerning CD4 cell count (absent in 16.5% of cases) and viral
load (which only began to be routinely performed in our
institution from 2000) were not systematically analyzed in
the present study, although eventually in existing cases, they
were useful for eventual consideration of immunodeﬁciency.
ThestandardizationsampleformicroscopyoftheCNSin
autopsies of our service is a minimum of three tissue blocks
with sample from diﬀerent lobes (one block), basal gan-
gliaandhippocampus(oneblock),midbrain,pons,andcere-
bellum (one block); additional blocks were taken from ma-
croscopic lesions. Paraﬃns e c t i o n s( 5μm) were stained with
hematoxylin-eosin and, where appropriate, special stain-
ing techniques were carried out for microorganisms and de-
myelinating disease assessment (Gram, Grocott, Mucicar-
min, Schiﬀ’s periodic acid, Fite Faraco, Luxol Fast Blue). Im-
munohistochemical reaction (polymer technique) was made
in some cases using monoclonal antibodies for toxoplasma
(Novocastra-NCL-TG-TP3), cytomegalovirus (Novocastra-
NCL-CMV-pp65), herpes virus (Dako HSV-I and II), JC
virus (Novocastra-NCL-JCBK) and for characterization ofAIDS Research and Treatment 3
lymphoma: CD3 (Dako-CD3-Leu, T3), CD20 (Novocas-
tra, NCL-CD20-L26), CD 30 (Dako-CD30 Ber-H2), CD45
(Dako CD45RO-UCHL1), CD45-LCA (Dako CD45, LCA-
2B11 + PD7/26). In situ hybridization for Epstein Barr was
performed in three cases of non-Hodgkin lymphoma.
Thecasesweredividedintothreegroups:(A)withoutany
antiretroviral medication; (B) use of 1 or 2 antiretrovirals
for any period of time, HAART for less than 3 months or
abandoned the use of HAART for more than 2 months; (C)
patientsonHAARTfor3monthsormore.Duringthereview
of the medical records, it was registered when HIV infection
diagnosis was made and the date of death, being calculated
thesurvivaltimeinmonths.PatientswhosediagnosisofHIV
infection was made at autopsy or during the hospitalization
inwhichdeathoccurred(hospitalstayfrom1to29days),the
survival time was considered zero. All pathological ﬁndings
found by CNS microscopic review were tabulated, as men-
tioned earlier. Then, it was assessed whether ﬁndings would
be important or not, clinically, not considering relevant focal
scarring (focal gliosis, mild mononuclear inﬁltrate in the
meninges, mild ependimite, meningeal ﬁbrous thickening),
focal/mild hemorrhage, mild edema, or edema resulting
from the ﬁnal event of the death. Next, where signiﬁcant
pathological ﬁndings in the CNS, or with evolutive potential,
were found we carried out a comparison with the clinical
hypotheses, in order to evaluate the pre-a n dpostmortem
agreement. For those cases with diagnostic disagreements
between the anatomopathological lesions in the CNS and
the clinical hypotheses, we used the classiﬁcation proposed
by Goldman et al. [32], simpliﬁed by de Almeida et al. [12],
separating them as follows: type 1 disagreement: an impor-
tant disease, which clinically diagnosed might had changed
the prognosis; type 2 disagreement: important disease not
diagnosed, however, if clinically diagnosed, would not have
changed the prognosis; type 3 disagreement: minor disease
not diagnosed, with doubtful or no inﬂuence on prognosis.
The morphological data from diﬀerent organs, recorded
in the autopsy reports, were used to assist in diagnosis of
immunodeﬁciency (such as, opportunistic infections indica-
tive of AIDS, according to the Centers for Disease Control,
CDC, USA, 1993) and also to evaluate the immediate cause
of death.
3. Results
From January 1989 to December 2008, 1785 autopsies were
madeinourhospital,and299(16.7%)casesshowedseropos-
itive for HIV. We excluded 15 of 299 cases: 9 for having no
criteria for deﬁning AIDS (according to the Centers for Dis-
ease Control, CDC, USA, 1993) and 6 by the absence of CNS
histological sections or no medical record found; therefore,
284 AIDS autopsies have been used in this study. Ninety of
these 284 cases (autopsies from 1989 to 1996) had already
beenpartlypreviouslyanalyzedintheauthor’smaster’sthesis
[33], corresponding to the period before the introduction of
HAART in our Institution. Eighty (28.2%) of 284 cases were
female; an increase in the percentage of the female popula-
tion was observed over the years evaluated, which was 17.8%
in the 1989 to 1996 period and increased to 33% from 1997
to 2008. Regarding age, considering a total of 284 cases, the
mean age was 35.7±10.8 years (minimum 16 and maximum
69 years). There was a slight increase when comparing the
period from 1989 to 1996 (34.3±11.3) to the one from 1997
to 2008 (36.3±10.5). The main risk factorsfor HIV infection
were drug abuse in 33.1% (94 of 284 cases; frequency of
37.2% among 204 male cases and 22.5% among 80 female
cases); homosexuality/bisexuality in 14.1% (homosexual-
ity/bisexuality in males 19.6%, while in female patients only
1%). Among 80 female cases, 22.5% reported as a risk factor
HIV-positive partner, and also 22.5% reported promiscuity.
Several patients reported 2 risk factors and in 27.1% of 284
cases there was no reference about the risk factor.
The percentage of cases with drug use was slightly
lower in the period 1989–1996 in comparison to that from
1997–2008 (35.6% versus 32%); yet regarding homosexu-
ality/bisexuality, until 1996 the frequency was much higher
than after 1997 (24.4% versus 9.3%), which likely results, at
least partially, of the increase of AIDS cases in women since
1997 (17.8% versus 33%).
Regarding the use of antiretroviral medication, since
1993 some patients were already using monotherapy; how-
ever, HAART was introduced in our service from 1997.
Although only 90 of the total 284 cases are before 1997,
most individuals in this study did not have any antiretroviral
treatment, ﬁtting them into group A (163 cases = 57.4%).
The large number of patients without use of antiretroviral
is probably due, in part, also to the fact that in 69 (24.3%)
cases the diagnosis of HIV infection was made at autopsy
(18 cases; minimum time of hospital stay 24 hours) or
during hospitalization in which death occurred (maximum
length of hospital stay 29 days), represented by 17 (18.9%)
of 90 cases before 1997, and 52 (26.8%) of 194, from
1997. In all 18 cases, whose diagnosis of HIV/AIDS was
made only after death, there were opportunistic infections in
CNS (toxoplasmosis or cryptococcosis) or in another organs
(cytomegalovirus, pneumocystis pneumonia, disseminated
mycobacteriosis, or histoplasmosis). These data demonstrate
that HIV patients evaluated in this study often sought late
medicalattention.Of284cases,75weretreatedwithHAART
for some time; however, 30 of these patients had used
HAART for less than 3 months or abandoned the treatment
for more than 2 months before death. These 30 patients,
added to 46 patients who used only one or two antiretroviral
constituted group B (76 cases, 26.8%). Then in group C were
only 45 (15.8%) cases.
3.1.CharacterizationandFrequencyofMorphologicalFindings
in the CNS According to the Study Groups. In 165 (58.1%) of
284—cases relevant brain lesions were identiﬁed. Through-
outtheperiodandstudiedgroups,infectiouslesions(54.2%)
greatly predominated in relation to neoplasms (2.5%) and
vascular lesions (1.1%). The result of these data is presented
in Table 1.
As shown in Table 1, toxoplasmosis was the most fre-
quent infection, seen in 85 (29.9%) of 284 cases, followed by4 AIDS Research and Treatment
Table 1: Relevant morphological lesions in the central nervous system in 284 autopsies of patients with acquired immunodeﬁciency
syndrome, according to the study groups.
Type of lesion Group A Group B Group C Total
n % n % n % n %
Infections 97 59.5% 35 46% 22 48.9% 154 54.2%
Protozoa 59 36.2% 19 25.0% 8 17.8% 86 30.3%
Toxoplamosis ∗59 36.2% 18 23.7% ∗8 17.8% 85 29.9%
Amebiasis 0 0 1 1.3% 0 0 1 0.3%
Fungal 30 18.4% 12 15.8% 7 15.6% 49 17.2%
Cryptococosis 27 16.6% 11 14.5% 7 15.6% 45 15.8%
Histoplasmosis 2 1.2% 0 0 0 0 2 0.7%
Paracoccidioidomycosis 1 0.6% 0 0 0 0 1 0.3%
Sporotrichosis 0 0 1 1.3% 0 0 1 0.3%
Bacterial †84 . 9 % 33 . 9 % 36 . 7 % †14 4.9%
Meningitis/encephalitis/abscess 5 3.1% 3 3.9% 3 6.7% 11 3.9%
Tuberculosis/mycobacteriosis 4 2.4% 0 0 0 0 4 1.4%
Virus 11 6.7% 22 . 6 % 6 13.3% 19 6.7%
Cytomegalovirus 5 3.1% 1 1.3% 1 2.2% 7 2.5%
Nodular encephalitis 2 1.2% 1 1.3% 0 0 3 1.2%
HIV ∗31 . 8 %0 0 ∗5 11.1% 8 2.8%
JC 1 0.6% 0 0 0 0 1 0.3%
Neoplasms 63 . 7 % 11 . 3 % 00 7 2 . 5 %
Lymphoid Neoplasms 4 2.4% 1 1.3% 0 0 5 1.8%
Meningiomas 2 1.2% 0 0 0 0 2 0.7%
Vascular lesions 00 1 1 . 3 % 24 . 4 % 31 . 1 %
Concomitant Lesions 11 3.9% 1 0.4% 2 0.7% 14 4.9%
Subtotal with relevant lesions 104 63.8% 37 48.7% 24 53.3% 165 58.1%
Subtotal normal or without relevants lesions 59 36.2% 39 51.3% 21 46.7% 119 41.9%
Total 163 100% 76 100% 45 100% 284 100%
Group A: without use of any antiretroviral medication; B: 1 or 2 antiretroviral therapy or HAART for any time less than 3 months; C: HAART for 3 months
or more; ∗P < 0.05; χ2 test. Nonrelevant lesions occurred in 103 (36.3%) of 284 cases, represented by focal alterations, scarring or just edema related to the
ﬁnal events; in only 16 (5.6%) cases the brain was completely normal. †Among the cases with bacterial infection in group A, one patient showed concomitant
infection by coccus and mycobacteria in diﬀerent regions of the CNS (9 bacterial infections/8 patients).
cryptococcosis in 45 (15.8%) cases, purulent bacterial infec-
tions in 11 (3.9%) cases, HIV encephalitis in eight (2.8%),
and cytomegalovirus infection in 7 (2.5%) cases. Regarding
noninfectious lesions, which occurred only in 10 (3.5%)
cases, 7 (2.5%) primitive CNS neoplasms and 3 (1.1%) vas-
cular lesions were identiﬁed. Among the tumors, there were
2 benign (Grade I meningiomas—World Health Organiza-
tion) and 5 lymphoid malignancies. These were represented
by a case of meningeal plasmablastic plasmacytoma and 4
(1.4%) non-Hodgkin’s lymphoma, diﬀuse type of B cells,
associated with Epstein Barr virus infection in all 3 cases
this agent was investigated by in situ hybridization. Vascular
lesions were represented by a case of subarachnoid hemor-
rhage in brainstem, a case of acute subdural hematoma and
a case of massive intraparenchymal hemorrhage. There was
no diﬀerence when compared the frequency of lesion among
the groups; however, toxoplasmosis was less common while
HIV encephalitis was more frequent in group C related to A.
A comparison of neuropathological lesions in 94 drug
abusers and 190 nondrug users showed that bacterial infec-
tions (including mycobacteria) were more frequent in drug
abusers (9.6% versus 2.6%, Fisher’s exact test, P = 0.01).
There was no statistically signiﬁcant diﬀerence in relation to
other lesions.
3.2. Analysis of the Relationship between Survival Time after
Diagnosis of HIV Infection and Use or not HAART. In 261
(90.9%) of 284 cases there were data on medical records to
measure the survival time after diagnosis of HIV infection.
Table 2 shows this result, according to the study groups.
As shown in Table 2, the mean survival time in group
C (49.1 months) was more than four times that in group
A (11.2 months) and almost twice as long in group B (25.8
months), showing clear beneﬁt of HAART.
3.3. Analysis if the Morphological Lesions in the CNS
(Postmortem) were Clinically Suspected or not (Premortem).
Disagreement was found between the clinical suspicion
(premortem) and neuropathological ﬁndings at autopsy
(postmortem) in 91 (55.1%) of 165 cases in which signiﬁcant
lesions in the CNS were observed, which represents 32%AIDS Research and Treatment 5
Table 2: Average values of survival time (months) after diagnosis of HIV infection in 261 of 284 autopsies of acquired immunodeﬁciency
syndrome, in which it was possible to obtain this information, according to the study groups.
Group AB C A l l c a s e s
N = 145 N = 71 N = 45 N = 261
Mean 11.2 25.8 49.1 21.7
Standard deviation 26.1 30.6 30.0 31.2
Median 1 11 48 6
Min-max value 0–192 0–132 6–144 0–192
Group A: without use of any antiretroviral medication; B: 1 or 2 antiretroviral therapy or HAART for any time less than 3 months; C: HAART for 3 months
or more; min: minimum, max: maximum. N: number of cases it was possible to obtain the survival time. Kruskal-Wallis/Dunn: P<0.001 when comparing
all groups.
compared to the total of 284 cases. In 49 (53.8%) of these
91 cases, which represent 17.2% of the total of 284 cases,
the disagreement was type 1, that is, important lesion was
not clinically diagnosed (premortem), which could alter the
prognosis; this occurred in all lymphoma cases. Regarding
thetime,thetypeIerrorwas62.2%(23of37discordantcases
with signiﬁcant CNS lesions) until 1996, then decreasing to
48.8% (26 of 54 discordant cases), probably partly due to
knowledge acquired through the study of the autopsies that
were reported through anatomoclinical sessions weekly.
In 22 (24.2%) of 91 cases, the disagreement was type
2, that is, important lesions were not diagnosed clinically
(premortem),buteveniftheydidwouldnotchangetheprog-
nosis; this occurred in several cases of cerebral toxoplasmosis
of patients who died due to lung infections by other agents.
In 20 (22%) of 91 cases, disagreement was type 3, that is, less
importantlesionswerenotdiagnosedclinically(premortem),
with doubtful or no inﬂuence on prognosis; as an example,
we could name meningioma in a patient with respiratory
failure due to pneumocystis pneumonia.
4. Discussion
Although Brazil is one of the countries with the largest
numberofAIDScases(about600,000patients)outofAfrica,
a slightly smaller number than the one estimated for the
entire Central and Western Europe [34], this is the ﬁrst
Brazilian study on AIDS autopsy (and also in developing
countries) to compare the neuropathological lesions pre-
and post-HAART era and to demonstrate that these lesions
are still frequent and are often not diagnosed clinically
(premortem). Necropsy is an important tool to understand
thelesionsinAIDSandseveralotherdiseases.However,there
has been an increasing reduction in the number of AIDS
autopsy, both in our material as in several other studies [19,
21, 22], probably because the complementary diagnostic and
clinicalexperiencehavecontributedtobettermanagementof
patients and in obtaining premortem diagnosis.
The percentage of women in our cases has increased
over the course of years (from 17.8% up to 1996 to 33%




in this study (35.7 years), which was lower than in developed
countries ranging from 38.4 to 40.5 years [2, 3, 21], probably
because survival rate is higher in these countries.
As for the overall frequency of neuropathological ﬁnd-
ings, we found that in 58.1% of our 284 cases there were
signiﬁcant morphological lesion; a higher value than that
found in the Brazilian clinical study De Oliveira et al. [35],
which was 46.5%. This diﬀerence probably results from
greater easiness to diagnose lesions at the anatomopatho-
logical study. However, our percentage was lower than the
values obtained by Masliah et al. [3], Morgello et al. [20],
Walsh et al. [23], Vago et al. [22], and Neuenburg et al. [21],
which ranged from 63% to 85%. However, if we compute in
our study all cases where there was some kind of CNS lesion
(relevant or focal lesions and just edema), as some authors,
our percentage would be 94.4%, similar to that found by
Chimelli et al. [9] in the pre-HAART era, which was 91.3%.
Table 3 shows a comparative summary of various series
of autopsies studies pre- and post-HAART, regarding to
neuropathological lesions.
Assessing the frequency of all neurological lesions rel-
evant in each group studied, a slightly higher percentage
was found in the group without antiretroviral treatment
(63.8%) than in the other groups (48.7% and 53.3%),
although these diﬀerences were not statistically signiﬁcant.
This result could give a false impression that HAART did not
alter the prognosis in AIDS; however, the survival time of
patients clearly shows beneﬁt of this therapy, although in the
ﬁnal stage, the cause of death is often by neuropathological
lesions. Our percentage of lesions in groups was smaller
than those of Jellinger et al. [2], which decreased from 80%
to 60%. It is possible this higher percentage elapses from
the larger CNS sample assessed by these authors, or from
not relevant lesions that might have been also computed.
Unfortunately, in our study the number of cases of group C
was small, perhaps indicating low adherence to HAART in
ourmidst,orpossiblybecauseusingthesedrugsmakeslower
mortality rates, resulting in fewer autopsies, as occurred in
several post-HAART studies [2, 19–22]. On the other hand,
when we began this study we thought that since 1997 almost
all patients would be under regular use of HAART protocol,
mainly because these medications are free in Brazil; however,
only 23.2% of 194 cases of this period used HAART for
3 months or more and 44.8% of these individuals did not
use any antiretroviral medication. These data are diﬃcult6 AIDS Research and Treatment
Table 3: Comparison between diﬀerent studies regarding lesions to the central nervous system, in a series of autopsies of patients with HIV
infection.
(a)
Pre-HAART N Les Tox Cry CMV HIV PML Nod Enc Lym Vas
Moskowitz et al. 1984 Miami, USA [4] 52 73.0 30.8 1.9 3.8 9.6 3.8 7.7 1.9 7.6
Anders et al. 1986 Los Angeles, USA [5] 89 74.0 6.7 12.4 15.7 ? 6.7 47.2 3.4 19.1
Petito et al. 1986 New York, USA [17] 153 80.0 10.0 <3 26.0 28.0 <3 17.0 6.0 0
Budka et al. 1987 Europe [15] 100 95.0 17.0 9.0 18.0 38.0 5.0 17.0 6.0 11.0
Lang et al .1989 Switzerland [7] 135 88.0 26.0 4.0 10.0 16.0 7.0 13.0 7.0
Chimelli et al. 1992 Rio/S.Paulo, Brazil [9] 252 91.3 34.1 13.5 7.9 10.7 0.8 6.7 3.9 7.9
Wainstein et al. 1992 P. Alegre, Brazil [18] 138 59.0 21.0 12.0 0 5.1 0 0 1.4 10.0
(b)
Post-HAART PN / NG Les Tox Cry CMV HIV PML Nod Enc Lym Vas
Masliah et al. 2000 California, USA [3] 1982–1998 390 63 2.8 5.6 18.5 26.9 3.1 0 9.5 0
Jellinger et al. 2000 Austria [2]
1984–1999 450
1984–1992 190 24.0 3.1 17.4 16.1 5.7 3.1 6.3 8.8
1993–1995 162 80.0 20.4 4.4 20.4 13.8 8.7 8.1 11.2 6.8
1996–1999 98 60.0 8.0 4.0 11.0 15.0 5.0 0 6.0 10.0
Morgello et al. 2002 New York, USA [20]
1979–2000 394 64.0 15.0 1.8 4.6
1979–1986 88 59.0 10.0 4.0 1.0
1987–1995 207 58.0 17.0 0 5.0
1996–2000 99 80.0 15.0 2.0 7.0
Neuenburg et al. 2002 Germany [21]
1985–1999 371 85.0 7.0 1.1 25.3 37.7 3.5 9.4 12.4
1985-1986 32 9.4 3.1 21.9 34.4 6.3 15.6
1987–1992 170 7.7 1.2 35.9 33.5 1.2 11.2
1993–1995 127 5.5 0.8 15.7 37.0 7.1 7.9
1996–1999 42 7.1 0 9.5 59.5 0 2.4










1997–2002 23 13.0 0 8.7 17.4 17.4 13.0
Walsh et al. 2004 Canada [23]
1985–2002 16 75.0 18.7 0 0 50.0 25.0 0 12.5 0
1 5 60.0 60.0 20.0 0
2 11 0 27.3 27.3 18.2
Silva et al. (current study) 2011 Uberaba,
Brazil [33]
1989–2008 284 58.1 29.9 15.8 2.5 2.8 0.3 1.1 1.4 1.1
A 163 63.8 36.2 16.6 3.1 1.8 0.6 1.2 1.8 0
B 76 48.7 23.7 14.5 1.3 0 0 1.3 1.3 1.3
C 45 53.3 17.8 15.6 2.2 11.1 0 0 0 4.4
N:n u m b e ro fc a s e s ,N G :n u m b e ro fc a s e si ne a c hg r o u p ;P: period; the last period corresponds to HAART; Les: lesion; all lesions are expressed in
percentages; Tox: toxoplasmosis; Cry: cryptococcosis, CMV: cytomegalovirus, HIV: HIV encephalitis/leukoencephalopathy; PML: progressive multifocal
leukoencephalopathy JC virus; Lym: primary central nervous system non-Hodgkin lymphoma; Vas: vascular lesion (infarction, hemorrhage). Only Gray
et al. Walsh et al. and the current study separated the groups by analyzing the therapy used in each patient; the others divided the groups according to
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to compare because many studies separated groups only
for period, without reviewing the clinical data regarding to
antiretroviral therapy (Table 3). Vago et al. [22]r e p o r t e d
to have collected data related to treatment only in the 4th
period: 90.6% used HAART, but the length of treatment was
not detailed. If we consider all patients who used HAART for
any time, they constitute 38.7% (75 of 194) of the autopsies
since 1997; however, considering the minimum duration
of 3 months for the eﬀectiveness of therapy, these cases
represent only 23.2% (45 of 194) of this period. Regarding
the type of lesion found, infections prevailed in all our
study groups, diagnosed in 54.2% of 284 cases, much lower
than that of Neuenburg et al. [21]a n dV a g oe ta l .[ 22],
which were 85% and 76%, respectively; diﬀerence found
perhaps due to more detailed sampling of the CNS, the
routine use of immunohistochemistry for various viruses or
regional diﬀerences. Considering the subtypes of infection,
toxoplasmosis was the most frequent in our study as a
whole (29.9%). Unlike Masliah et al. [3], Neuenburg et al.
[21] and Walsh et al. [23], whose global percentage of
toxoplasmosis ranged from 2.8% to 18.7% and where HIV
infections prevailed, it also occurred in pre-HAART studies
fromAndersetal.[5],Petitoetal.[17],andBudkaetal.[15],
whose toxoplasmosis frequencies ranged from 6.7% to 17%
and cytomegalovirus and HIV encephalitis predominated.
These diﬀerences are likely to be related to environmental,
geographic and socioeconomic factors. The pre-HAART
Brazilians autopsy studies [9, 18] corroborate these ideas,
as toxoplasmosis was the most frequent infection ranging
from 21% to 34.1%. This diﬀerence between studies in
developed countries and ours also persisted in the isolated
analysisofthegroupusingHAART.Inspiteofthestatistically
signiﬁcant reduction in frequency of toxoplasmosis among
our untreated group, compared to the one in use of HAART
(36.2% versus 17.8%), these values were higher than those
found in studies from developed countries, in which there
was reduction of 24% to 8% [2], from 9.4% to 7.1% [21],
and 60% to 0% [23]. The second most common infec-
tion in our study was cryptococcosis, present in 15.8% of
cases and similar in the three subgroups of this study; it was
more frequent in our material, even in the HAART group
(15.6%) than in the corresponding groups from Neuen-
burg et al. [21], Jellinger et al. [2], and Masliah et al. [3],
whose percentage ranged from 0 to 5.6%. Those diﬀerences
could be explained, at least in part, because many patients
in our country seek medical help when already presenting
with advanced neurological disease, aﬀecting the diagno-
sis and treatment. Viral infections, which together repre-
sent more than 50% of lesions in the CNS studies in
developed countries, even in the pre-HAART period [5,
7, 15, 17], were not common in our series, accounting
for only 6.7% of 284 cases, while infections by protozoa,
fungi and bacteria amounted to 49.3% in our material. HIV
encephalitis occurred in 2.8% of total cases in our study,
cytomegalovirusin2.5%andJCvirusinfectioninonly0.3%.
This lower percentage of viral infections in relation to other
series of autopsies is probably justiﬁed due to the lower
survival rates of our patients, with not enough time avai-
lable for the development of HIV neuropathological lesions,
complicating prior by opportunistic infections, as our pa-
tients usually seek medical treatment in advanced stages
of AIDS. As to the comparison of viral infections between
the groups, cytomegalovirus infection was more frequent
in our group without antiretroviral drugs (3.1%), while in
the HAART group there was predominance of HIV enceph-
alitis (11.1%). This change is probably related to the longer
survival of patients on HAART, as it has already been
observed in developed countries for several years. However,
the percentage of lesion by HIV was much lower, even
in our HAART group, than in other series post-HAART
[2, 3, 19–23], in which it varied between 15% and 59.5%.
In some of these studies there was a slight reduction in
HIV CNS infection over the periods studied [19, 22, 23],
unlike others who showed an increase [3, 21], but as mild or
moderateforms.ProbablythelowestfrequencyofHIVlesion
in our HAART group, is due in part to the fact that immu-
nohistochemistry was not performed in our study, and HIV
encephalitis diagnosis was made by the direct visualization
of multinucleated giant cells, unlike several of these studies
thatperformedroutineimmunohistochemicalasNeuenburg
et al. [21], whose percentage of lesion by HIV in HAART
group was 59.5%. In addition to possible socioeconomic and
geographic factors, in our material there was still a high
frequency of toxoplasmosis and cryptococcosis, which may
have slightly reduced the survival of this group of patients.
Rare infections in the CNS as paracoccidioidomycosis,
sporotrichosis, infection by free-living amoeba (Balamuthia
mandrilares), were not reported in other studies and may be
related to environmental and regional factors.
Noninfectious lesions occurred in 3.5% of our cases, also
no signiﬁcant diﬀerence between groups (3.7%, 2.6%, and
4.4%); 1.4% represented by primary CNS lymphomas and
none of these cases was diagnosed premortem. In the series of
Jellinger et al. [2] the frequency of this neoplasm was much
higher in all time periods, ranging between 6% and 11.2%,
as in others post-HAART studies, which ranged from 2.4%
to 18.2% [19–21, 23]. Probably because survival is higher in
developed countries and frequency of opportunistic infec-
tions, lower. Important vascular lesions occurred in 4.4%
of our HAART group, having been described in 10% in a
corresponding group from Jellinger et al. [2] and 19.1% in
the pre-HAART study from Anders et al. [5]. They were
infrequent in our study, occurred only in groups B and
C, and could not be directly related to AIDS. Such large
diﬀerences between the various series can be explained, at
least in part, by the way we reported those lesions, as in our
percentage we considered only the relevant lesions such as
extensive bleeding, while Anders et al. [5] reported “bleeding
of variable intensity.” Given these data we can conclude that
neuropathological lesions, even with the use of HAART, are
still common in patients with AIDS, which is consistent with
the observations reported by other authors [2, 3, 19, 21, 22].
Regarding the analysis of survival time after HIV infec-
tion diagnosis and use or not of HAART—which our
study clearly demonstrated the beneﬁt of this medication—
no detailed assessment was found in the other series of
autopsies, but only comments on the study from Jellinger
et al. [2] and Neuenburg et al. [21], who stated that survival8 AIDS Research and Treatment
was increased after HAART. Our data conﬁrm the concepts
already well known clinically and are also in agreement with
thereductioninthenumberofautopsiesperformedonAIDS
afterthe introduction ofHAART,althoughotherfactorsmay
be involved in this issue, such as the possibility of an earlier-
achieved diagnosis of HIV infection.
Forthecorrelationbetweenclinicalandautopsyﬁndings,
no similar study was found in autopsies of AIDS in relation
to the CNS. Wilkes et al. [14] made a review of 101 autopsies
of AIDS in pre-HAART era, comparing pre-a n dpostmortem
diagnoses in various organs; they reported that 74% of cases
had lesions not suspected clinically. Another more recent
study compared pre-a n dpostmortem diagnosis in AIDS,
although very detailed and classifying errors, assessed only
invasive mycoses in diﬀerent organs. In 36.9% of cases in
which this infection was the major disease, this diagnosis
was not made clinically [31]. In our series disagreement was
observedin91(55.1%)of165caseswithsigniﬁcantlesionsin
the CNS (or 32% of the total 284 cases). Disagreement type 1
(important disease that if diagnosed in life could change the
patient prognosis) occurred in 49 (53.8%) of 91 discordant
cases, representing 17.6% of the total 284 cases studied.
These data demonstrate that even serious lesions are still not
suspected clinically, probably because of clinical similarities
and very diﬃcult diﬀerential diagnosis, which reinforces the
importanceofautopsystudiestoimproveunderstandingand
knowledge of brain lesions, which are common and still
prevalent, even with the use HAART and the presence of
advanced diagnostic technologies.
5. Conclusions
The present study and other series of autopsies post-HAART
have shown that despite beneﬁcial eﬀect of HAART, the
lesions in the CNS continue to be frequent and important
cause of death in AIDS patients. However, the median
survival time in our HAART group was four times higher
compared to those without antiretroviral, which has not
been evaluated in other studies of autopsies. Toxoplasmosis
remained the most frequent CNS infection, despite HAART,
but was less common in our HAART group (17.8% versus
36.2%) while HIV encephalitis was more frequent (11.1%
versus 1.8%). Nevertheless, the percentage of Brazilian
toxoplasmosis is more similar to the pre-HAART studies
than the post-HAART from developed countries, probably
reﬂecting geographical or socioeconomic and cultural
factors. Disagreement between the pre- and postmortem
diagnosis occurred in 91 (55.1%) of 165 cases with relevant
brain lesions at autopsy; in 49 (53.8%) of these 91 cases
(17.2% of the total 284) was disagreement type 1: it was not
diagnosed signiﬁcant lesion premortem, which could change
theprognosis,indicatingtheimportanceoftheautopsy,even
with HAART and with advanced diagnostics technologies.
The reduction of type I error percentage (62.2% until
1996 to 48.8% after 1996), may have been at least partly
resulting from the knowledge acquired through the autopsy
study, which was reported through anatomoclinical sessions
weekly.
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